Loading component...
CURRENT OFFERINGS
FOR INSTITUTIONAL USE ONLY. NOT FOR DISTRIBUTION TO THE PUBLIC. CUSIP Disclaimer
This material is for institutional use only and may not be distributed to any individual investor or other third-party. InspereX LLC (“InspereX”) and its affiliates explicitly disclaim any responsibility for product suitability or suitability determinations related to individual investors. This information should not be regarded by recipients as a substitute for the exercise of their own independent judgment and the information provided herein is not an offer, solicitation or a recommendation to buy, sell or hold any security or investment strategy. There can be no assurance that the investments shown herein were or will be profitable and this material does not take into account any investor’s particular investment objectives, financial situation, particular needs, strategies, tax status or time horizon. Further, any material contained herein should not be considered, construed, or followed as research material.
Past performance is no guarantee of future results. All investments carry a certain degree of risk and there is no assurance that an investment will provide positive performance over any time period. Different time periods and market conditions may result in significantly different outcomes. Any financial product sold prior to maturity may be worth more or less than the original amount invested. Depending upon the specific product offering, investment risks include, but are not limited to, market risk, interest rate risk, credit risk, call risk and liquidity risk. Additionally, unless otherwise specified in the respective offering documentation, the product(s) discussed herein are not FDIC insured, may lose value, and are not bank guaranteed.
These financial products are sold only by the offering documents and supplements of the respective issuer. The terms of each offering are subject to change or an offering may be cancelled, without advance notice from the issuer or InspereX. Such changes could include the early closure of an offering period, as well as a change to the corresponding price, yield and/or selling concession or reallowance. Indications of interest and orders submitted to InspereX shall not be executed until confirmed in writing by InspereX. If a financial product includes a Survivor's Option, please see the applicable offering document for the terms and conditions thereof. All transactions between your firm and InspereX shall be governed by the respective selling agreement between InspereX and your firm.
This material may not contain a complete discussion of investment terms or risks and you should only rely on the information contained in relevant prospectus and/or offering documentation prior to purchasing an investment product or making a recommendation to a customer. A copy of the relevant registration statement, terms sheet, pricing supplement, preliminary official statement (POS) and official statement (OS), financial reports and/or other offering information for registered securities and certain exempt securities may be found at the SEC’s EDGAR database (https://www.sec.gov/search-filings) or the MSRB’s EMMA database (https://emma.msrb.org/).
The information contained herein does not constitute an offer to sell or a solicitation of an offer to buy securities. Investment products described herein may not be offered for sale in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful or prohibited by the specific offering documentation.
This information is subject to change without notice. InspereX does not warrant the accuracy or completeness of any information contained herein and provides no assurance that this information is, in fact, accurate. Data provided by third-party sources is believed to be reliable, and there is no representation or warranty as to the current accuracy of, or liability for, decisions made based on this material. Neither InspereX, its affiliates, nor its partners make any representations or guarantees as to the accuracy or completeness of data from third-party sources.
Signifies Impact Investment*Annualized Coupon: Investors should be mindful of the stated maturity dates above as all products are quoted per annum, even in maturities of less than one year. Accordingly, the actual coupon rate will be less than the stated annualized coupon for these offerings. Annualized coupons are based upon a 360-day year, so the coupons for products maturing in less than a year should be recalculated based upon the number of days until maturity. For example, a product with a stated 10 percent per annum coupon provides an actual return of roughly 2.5 percent (based on a 360-day year) over a three-month term.
**Contingent Downside Protection: In a reverse convertible note, Downside Protection is the percent difference between the barrier price and the initial price of the underlying stock. If the underlying stock(s) closes below the barrier price on any day during the observation period, the investor is at risk of receiving at maturity a predetermined number of shares of the underlying stock (or their cash equivalent) rather than the principal amount of the notes.
***Credit Linked Notes and Credit Risk Credit linked notes are subject to the risk of loss of principal as well as the credit risk of the issuer and the referenced entities. Credit risk is the risk of loss caused by borrowers, bond obligors, guarantors, or counterparties failing to fulfil their obligations or the risk of such parties’ credit quality deteriorating. Exposure to the credit risk of one or more referenced entities is particularly relevant to any credit linked product, such as credit linked notes. When investing in credit linked notes, the potential losses, which may be sustained, and the frequency and likelihood of such losses occurring may be substantially greater than when investing in an obligation of the referenced entity(ies) itself(themselves). While a credit rating by a ratings agency does not guarantee the safety of principal, it does provide an independent opinion. Investors should understand the claims paying ability of the issuer as well as the referenced entity(ies) before investing in credit linked products.